|Products and Services:||1,105|
|Articles and publications:||403|
|Tenders & Vacancies:||3|
For over 30 years, ID Care’s clinical epidemiology and research has been pioneering a variety of state-of-the-art clinical trials* — and we’re at the forefront of cutting-edge treatment options. That means we’re giving you access to some of the most effective medications available today. Not only has our clinical epidemiology and research significantly helped innumerable individuals improve their health — it’s also helped expand the medical knowledge of the broader infectious disease medical community.
The ID Care Research Team includes highly trained physicians, a full-time infectious disease research team, as well as administrative and support staff — all united by an unwavering dedication to the health and well-being of our patients. Since the inception of our program, we’ve performed over 100 medication studies and delivered new and improved treatments for patients with infectious diseases. From the development of significant therapeutic advances for HIV and hepatitis to the facilitation of rapid, new testing technologies for Lyme disease, we’re steadfast in the pursuit of the best possible treatment options for every patient we serve.
To find out more about our infectious disease research programs and the opportunities available to you and your loved ones, please contact the ID Care Research Department at 908-281-0221 extension 6.
*There are potential risks to participation in a clinical trial, which may include unpleasant, serious or even life-threatening side effects to experimental treatment. The experimental treatment may not be effective for the participant, and the protocol may require more of their time and attention than would a non-protocol treatment.
Infectious Disease Specialists